Stock Rating Downgrade
The Value Trend Rating for Axsome Therapeutics Inc (NASDAQ: AXSM) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Axsome Therapeutics Inc (NASDAQ: AXSM) stock declined modestly by -1.8% on 3/7/25. The stock closed at $122.17. However, trading volume in this decline was exceptionally low at 47% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -3.4% during the last week.
Current PriceTarget Research Rating
Axsome Therapeutics has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Axsome Therapeutics has a poor Appreciation Score of 15 but a slightly positive Power Rating of 68, producing the Negative Value Trend Rating.
Be the first to comment